IRME Stock Chart & Stats
$0.04
$0.08(16.66%)
At close: 4:00 PM EST
$0.04
$0.08(16.66%)
Day’s Range― - ―
52-Week Range$0.01 - $0.06
Previous CloseN/A
Volume729.00
Average Volume (3M)29.99K
Market Cap
$204.49K
Enterprise Value$727.67K
Total Cash (Recent Filing)$63.00K
Total Debt (Recent Filing)$250.00K
Price to Earnings (P/E)―
Beta-0.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding97,377,690
10 Day Avg. Volume510
30 Day Avg. Volume29,988
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)-112.07
Price to Sales (P/S)0.00
P/FCF Ratio-23.77
Enterprise Value/Market Cap3.56
Enterprise Value/Revenue27.99
Enterprise Value/Gross Profit363.84
Enterprise Value/Ebitda-0.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.17
Revenue Forecast (FY)$30.90M
IR-Med News
IRME FAQ
What was IR-Med’s price range in the past 12 months?
IR-Med lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.
What is IR-Med’s market cap?
IR-Med’s market cap is $204.49K.
When is IR-Med’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IR-Med’s earnings last quarter?
Currently, no data Available
Is IR-Med overvalued?
According to Wall Street analysts IR-Med’s price is currently Overvalued.
Does IR-Med pay dividends?
IR-Med does not currently pay dividends.
What is IR-Med’s EPS estimate?
IR-Med’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IR-Med have?
IR-Med has 97,377,690 shares outstanding.
What happened to IR-Med’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IR-Med?
Currently, no hedge funds are holding shares in IRME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IR-Med
IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.